Companies: 11,396     total market cap: โ‚น14030.221 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sarepta Therapeutics
SRPT
#5162
Rank
โ‚น165.12 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น1,540
Share price
-4.76%
Change (1 day)
0.52%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น155.74 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are โ‚น155.74 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น200.23 B-11.8%
2022-12-31โ‚น227.01 B37.39%
2021-12-31โ‚น165.23 B1.64%
2020-12-31โ‚น162.57 B126.93%
2019-12-31โ‚น71.64 B68.02%
2018-12-31โ‚น42.63 B28.73%
2017-12-31โ‚น33.12 B457.6%
2016-12-31โ‚น5.94 B7.13%
2015-12-31โ‚น5.54 B84.65%
2014-12-31โ‚น3.00 B9.53%
2013-12-31โ‚น2.74 B-38.42%
2012-12-31โ‚น4.45 B260.42%
2011-12-31โ‚น1.23 B-43.5%
2010-12-31โ‚น2.18 B29.46%
2009-12-31โ‚น1.68 B258.39%
2008-12-31โ‚น0.47 B-2.03%
2007-12-31โ‚น0.48 B244.67%
2006-12-31โ‚น0.13 B12.85%
2005-12-31โ‚น0.12 B26.93%
2004-12-31โ‚น97.42 M-42.95%
2003-12-31โ‚น0.17 B-30.47%
2002-12-31โ‚น0.24 B55.15%
2001-12-31โ‚น0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
โ‚น3.527 T 2,165.18%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น320.33 B 105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น107.49 B-30.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น411.77 B 164.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น140.65 B-9.69%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น94.91 B-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น25.26 B-83.78%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com